[The role of vaping in smoking cessation].

The electronic cigarette, or vape, has emerged over the last ten years as an alternative way of helping people give up smoking. Tobacco-free, they produce vapor and deliver only minute levels of toxic substances and carcinogens. Several studies confirm the effectiveness of nicotine vaping products in helping people to stop smoking.

[How can we prevent teenage smoking ?].

Smoking rates in Europe are falling steadily among teenagers. The main reasons why young people start smoking are highlighted. Preventing young people from starting to smoke is based on a combination of three approaches: firstly, interventions in schools, incorporating educational programs from an early age; secondly, comprehensive tobacco control measures, such as bans on sales to minors and higher taxes on tobacco products; -thirdly, targeted communication campaigns.

[The shared educational assessment in the smoking cessation process].

In the context of smoking cessation, the shared educational assessment (BEP) enables us to assess the smoker's needs, define specific objectives and set up appropriate educational workshops. This multidisciplinary approach helps smokers to maintain their smoking cessation. The BEP is the first step in the educational process, exploring the various classic dimensions of therapeutic patient education (TPE) and then defining an action plan based on the priorities identified.

[Smoking cessation in smokers under treatment for lung cancer. Current data].

In 2020, lung cancer was the cause of 18 % of all cancer deaths; smoking accounting for around 90 % of all lung cancers. Despite advances in lung cancer treatment, tobacco control measures are the most effective in curbing the lung cancer epidemic. Nevertheless, smoking cessation at all stages of the cancer process is associated with benefits in terms of cure, improved life expectancy and quality of life for patients, reduced medical or surgical complications, and reduced risk of recurrence or occurrence of a second primary cancer.

[Bronchial diseases and heroin use. A systematic review].

Introduction: Heroin use can cause respiratory complications including asthma, chronic obstructive pulmonary disease (COPD) and bronchiectasis (BD).

Objectives: A general review of the literature presenting the data on the relationships between heroin consumption and bronchial complications, while underlining the difficulties of diagnosis and management.

Documentary Sources: Medline, 1980-2022, keywords "asthma" or "bronchospasm" or "COPD" or "bronchiectasis" and "heroin" or "opiate" or "opiates", with limits pertaining to "Title/Abstract".

[Smoking cessation treatment for smokers with COPD: The importance of therapeutic education].

Smoking is a major risk factor for chronic obstructive pulmonary disease (COPD). The diagnosis of tobacco addiction and management of tobacco dependence are part and parcel of COPD treatment, especially in respiratory rehabilitation. Management encompasses psychological support, validated treatments and therapeutic education.

[Diffuse alveolar hemorrhage in cannabis smokers. A systematic literature review].

Cannabis is the most widely used illicit psychoactive substance in France. It can be responsible for numerous pulmonary complications, including diffuse alveolar hemorrhage (DAH). The objective of this systematic review of the literature was to present data concerning the relationship between cannabis smoking and DAH, which has rarely been reported in the literature.

[Inhaled marijuana and the lung, a toxic cocktail?].

Unlike the well-documented effects of tobacco smoke on the lung, the effects of cannabis smoke remain controversial, the main bias consisting in co-consumption of tobacco. That said, the composition of joint smoke is close to that of cigarettes, containing many compounds that are carcinogenic and/or alter the respiratory epithelium. Confirmed respiratory effects in chronic cannabis smokers include aggravated chronic bronchitis symptoms, a cumulative effect with tobacco on COPD and emphysema occurrence, an increased risk of bullous emphysema, and pneumothorax with heightened risk of recurrence after pleural symphysis.

[Combinations of pharmacological treatments in smoking cessation. A systematic review].

Introduction: The effectiveness of the three validated smoking cessation medications, nicotine replacement therapy, varenicline and bupropion, may be insufficient, in hard-core smokers.

Objectives: This systematic review investigates the efficacy of combinations of different medications in smoking abstinence and their tolerability.

Results: Three randomized controlled trials (RCTs) compared the combined medications with varenicline and nicotine patches vs.

[Contribution of electronic cigarettes in smoking patients with psychotic disorders. A literature review].

Objectives: This systematic literature review focused on patients suffering from schizophrenia (SZ), psychotic disorders or mental illness (MI) including SZ. It was interested in data on prevalence of electronic cigarette (EC) use, patient perceptions and expectations, as well as caregivers' attitudes towards the EC and its benefit in helping to stop or reduce smoking.

Method: The research was carried out on Medline for the period 2000-2020.

[COPD, anxiety-depression and cognitive disorders: Does inflammation play a major role?].

COPD is a chronic respiratory disease, often associated with extrapulmonary manifestations. Co-morbidities, including anxiety, depression and cognitive impairment, worsen its progression and quality of life. The prevalence of these disorders is high, yet they are often poorly understood and inadequately managed.

[Smoking cessation in smokers with pulmonary Langerhans cell histiocytosis - considerations from the management of ten patients].

Pulmonary Langerhans cell histiocytosis (PLCH) belongs to the spectrum of diffuse interstitial cystic pneumonias; it affects young people of both sexes and occurs almost exclusively in tobacco smokers or co-users of tobacco and cannabis. The management of this severe chronic disease is undertaken in specialized centers. A better understanding of the pathogenic mechanisms of the disease has opened up prospects for targeted therapies.

[Tobacco and cannabis consumption : toxicity and management of quitting].

The use of cannabis is most often associated with that of tobacco. While the addictive power of cannabis is low, that of tobacco is high. The regular use of both tobacco and cannabis is at the origin of the increase in dependence on each substance, which makes stopping this double consumption often difficult.

[Smoking cessation in asthmatic patients and its impact].

Introduction: The prevalence of smoking in asthmatic patients is similar to, or even higher than in the general population.

Objectives: This systematic review addresses (1) the effects of smoking on asthma, (2) smoking cessation strategies in asthmatic patients, and (3) the consequences of smoking cessation for people with asthma.

Results: Active or passive smoking can promote the development of asthma.

[Smoking cessation and lung cancer screening].

Several studies have shown that lung cancer screening, using annual low-dose computed tomography (CT) scan in a targeted population of smokers and ex-smokers reduces overall and lung cancer specific mortality rates. This form of screening strategy is not currently established for use in France by the French High Authority for Health. Quitting smoking is the most important measure in reducing mortality from lung cancer.

[Electronic cigarette use in patients with asthma].

The proportion of patients whose asthma is poorly controlled due to their smoking remains high. Electronic cigarette (EC) is a new tool to help people stopping smoking, which substitutes a much less irritating aerosol to very toxic cigarette smoke, but it cannot be considered completely healthy. It represents a possible assistance for asthmatic smokers who wish using it to stop smoking.